Ureteral Stents Market by Product - Global Opportunity Analysis and Industry Forecast, 2017-2023

  • ID: 4403152
  • Report
  • Region: Global
  • 150 pages
  • Allied Analytics LLP
1 of 3
Ureteral stents are used to prevent and treat the blocked ureter, thus allowing urine flow from the kidney. These thin tube are implanted into the ureter with the aid of a cystoscope. The global ureteral stents market was valued at $304 million in 2016, and is estimated to reach $449 million by 2023, growing at a CAGR of 5.7% from 2017 to 2023.

Increase in number of kidney transplantation cases across the world, sedentary lifestyles, rise in geriatric population, and surge in incidence of urological diseases, such as kidney stones and urinary incontinence, drive the market growth. In addition, rapid technological advancements, increase in awareness of the population about the treatment of urological diseases, and improvement in healthcare infrastructure fuel the market growth. However, inadequate availability of skilled professionals and complication associated with the use of stents are expected to restrain the market growth. Conversely, introduction of smart phone applications such as ureteral stent tracker by various key vendors and increase in healthcare investment in emerging nations are expected to provide numerous opportunities for market growth in the near future.

The market is segmented on the basis of product, material, application, end user, and geography. Based on product, the market is classified into open end stents, double pigtail stents, closed end stents, and multiloop stents. By material, it is categorized into metallic stents, and polymer stents. Polymer stents is further sub segmented into silicone stents, hybrid stents, and polyurethane stents. The application segment includes kidney stones, kidney transplantation, tumors, urinary incontinence, and others. Kidney stones segment is further segmented into ureteroscopy, lithotripsy, and percutaneous nephrolithotomy. Depending on end user, the market is divided into hospitals, clinics, and ambulatory surgical centers. Geographically, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, Italy, UK, Spain, and rest of Europe), Asia-Pacific (China, Japan, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

KEY BENEFITS FOR STAKEHOLDERS

The study provides an in-depth analysis of the global ureteral stents market with current trends and future estimations to elucidate the investment pockets.
Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
The report offers a quantitative analysis to assist the stakeholders to capitalize on prevailing market opportunities.
Extensive analysis of different segments facilitates to determine various products available in the market.
Key players are profiled and their strategies are analyzed thoroughly to predict the competitive market outlook.

KEY MARKET SEGMENTS

BY PRODUCT

Open End Stents
Closed End Stents
Double Pigtail Stents
Multiloop Stents

BY MATERIAL

Metallic Stents
Polymer Stents
Silicone Stents
Hybrid Stents
Polyurethane Stents

By Application

Kidney Stones
Ureteroscopy
Lithotripsy
Percutaneous Nephrolithotomy
Kidney Transplantation
Tumors
Urinary Incontinence
Others

BY END USER

Hospitals
Clinics
Ambulatory Surgical Centers (ASCs)

BY REGION

North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Spain
Italy
Rest of Europe
Asia-Pacific
Japan
China
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT

Boston Scientific Corporation
B. Braun Holding GmbH & Co. KG
Cook Group Incorporated
C. R. Bard, Inc.
Coloplast Ltd.
Medline Industries, Inc.
Allium Medical Solutions Ltd.
Pnn Medical A/S
Teleflex Incorporated
Olympus Corporation

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on client requet.)
GBUK Healthcare Ltd.
Red Leaf Medical
Dextronix, Inc.
ROCAMED
Akina, Inc.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top winning strategies
3.2.2. Top investment pockets

3.3. MARKET SHARE ANALYSIS, 2016
3.4. MARKET DYNAMICS

3.4.1. Drivers

3.4.1.1. Increase in prevalence of urological disorders
3.4.1.2. Growing geriatric population
3.4.1.3. Rising number of kidney transplants
3.4.1.4. Technological advancements in stent design and composition material

3.4.2. Restraints

3.4.2.1. Complications associated with ureteral stent
3.4.2.2. Dearth of skilled professionals

3.4.3. Opportunities

3.4.3.1. Growing healthcare infrastructure and increase in healthcare investment in emerging nations
3.4.3.2. Development of innovative smart phone applications for ureteral stents

3.4.4. Impact analysis

CHAPTER 4 GLOBAL URETERAL STENTS MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. OPEN END STENTS

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. CLOSED END STENTS

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.4. DOUBLE PIGTAIL STENTS

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast

4.5. MULTILOOP STENTS

4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast

CHAPTER 5 GLOBAL URETERAL STENTS MARKET, BY MATERIALS

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. METALLIC STENTS

5.2.1. Key market trends
5.2.2. Growth factors and opportunities
5.2.3. Market size and forecast

5.3. POLYMER STENTS

5.3.1. Key market trends
5.3.2. Growth factors and opportunities
5.3.3. Market size and forecast
5.3.4. Silicone Ureteral Stents

5.3.4.1. Market size and forecast

5.3.5. Hybrid Ureteral Stents

5.3.5.1. Market size and forecast

5.3.6. Polyurethane Ureteral Stents

5.3.6.1. Market size and forecast

CHAPTER 6 GLOBAL URETERAL STENTS MARKET, BY APPLICATION

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. KIDNEY STONES

6.2.1. Market size and forecast
6.2.2. Ureteroscopy

6.2.2.1. Market size and forecast

6.2.3. Lithotripsy

6.2.3.1. Market size and forecast

6.2.4. Percutaneous Nephrolithotomy

6.2.4.1. Market size and forecast

6.3. KIDNEY TRANSPLANTATION

6.3.1. Market size and forecast

6.4. TUMORS

6.4.1. Market size and forecast

6.5. URINARY INCONTINENCE

6.5.1. Market size and forecast

6.6. OTHER APPLICATIONS

6.6.1. Market size and forecast

CHAPTER 7 GLOBAL URETERAL STENTS MARKET, BY END USER

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. HOSPITALS

7.2.1. Market size and forecast

7.3. CLINICS

7.3.1. Market size and forecast

7.4. AMBULATORY SURGICAL CENTERS (ASCS)

7.4.1. Market size and forecast

CHAPTER 8 GLOBAL URETERAL STENTS MARKET, BY REGION

8.1. OVERVIEW

8.1.1. Market size and forecast

8.2. NORTH AMERICA

8.2.1. Key market trends
8.2.2. Key growth factors and opportunities
8.2.3. Market size and forecast
8.2.4. U.S.
8.2.5. Canada
8.2.6. Mexico

8.3. EUROPE

8.3.1. Key market trends
8.3.2. Key growth factors and opportunities
8.3.3. Market size and forecast
8.3.4. GERMANY
8.3.5. UK
8.3.6. FRANCE
8.3.7. SPAIN
8.3.8. ITALY
8.3.9. REST OF EUROPE

8.4. ASIA-PACIFIC

8.4.1. Key market trends
8.4.2. Key growth factors and opportunities
8.4.3. Market size and forecast
8.4.4. JAPAN
8.4.5. CHINA
8.4.6. INDIA
8.4.7. SOUTH KOREA
8.4.8. REST OF ASIA-PACIFIC

8.5. LAMEA

8.5.1. Key market trends
8.5.2. Key growth factors and opportunities
8.5.3. Market size and forecast
8.5.4. BRAZIL
8.5.5. SOUTH AFRICA
8.5.6. SAUDI ARABIA
8.5.7. REST OF LAMEA

CHAPTER 9 COMPANY PROFILES

9.1. BOSTON SCIENTIFIC CORPORATION

9.1.1. Company overview
9.1.2. Operating business segments
9.1.3. Business performance
9.1.4. Key strategic moves and developments

9.2. B. BRAUN HOLDING GMBH & CO. KG

9.2.1. Company overview
9.2.2. Operating business segments
9.2.3. Business performance
9.2.4. Key strategic moves and developments

9.3. COOK GROUP INCORPORATED

9.3.1. Company overview
9.3.2. Operating business segments
9.3.3. Business performance
9.3.4. Key strategic moves and developments

9.4. C. R. BARD, INC.

9.4.1. Company overview
9.4.2. Operating business segments
9.4.3. Business performance
9.4.4. Key strategic moves and developments

9.5. COLOPLAST LTD.

9.5.1. Company overview
9.5.2. Operating business segments
9.5.3. Business performance
9.5.4. Key strategic moves and developments

9.6. MEDLINE INDUSTRIES, INC.

9.6.1. Company overview
9.6.2. Operating business segments
9.6.3. Business performance
9.6.4. Key strategic moves and developments

9.7. ALLIUM MEDICAL SOLUTIONS LTD.

9.7.1. Company overview
9.7.2. Operating business segments
9.7.3. Business performance
9.7.4. Key strategic moves and developments

9.8. PNN MEDICAL A/S

9.8.1. Company overview
9.8.2. Operating business segments
9.8.3. Business performance
9.8.4. Key strategic moves and developments

9.9. TELEFLEX INCORPORATED

9.9.1. Company overview
9.9.2. Operating business segments
9.9.3. Business performance
9.9.4. Key strategic moves and developments

9.10. OLYMPUS CORPORATION

9.10.1. Company overview
9.10.2. Operating business segments
9.10.3. Business performance
9.10.4. Key strategic moves and developments
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll